PT906106E - Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca) - Google Patents
Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca) Download PDFInfo
- Publication number
- PT906106E PT906106E PT97925934T PT97925934T PT906106E PT 906106 E PT906106 E PT 906106E PT 97925934 T PT97925934 T PT 97925934T PT 97925934 T PT97925934 T PT 97925934T PT 906106 E PT906106 E PT 906106E
- Authority
- PT
- Portugal
- Prior art keywords
- colonic
- prevention
- treatment
- fudca
- microadenoma
- Prior art date
Links
- 230000002265 prevention Effects 0.000 title abstract 3
- 239000002253 acid Substances 0.000 title abstract 2
- 206010048832 Colon adenoma Diseases 0.000 title 1
- 230000000112 colonic effect Effects 0.000 title 1
- 238000000034 method Methods 0.000 abstract 3
- 208000003200 Adenoma Diseases 0.000 abstract 1
- 206010001233 Adenoma benign Diseases 0.000 abstract 1
- 206010009944 Colon cancer Diseases 0.000 abstract 1
- 208000001333 Colorectal Neoplasms Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 239000003613 bile acid Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 231100000357 carcinogen Toxicity 0.000 abstract 1
- 239000003183 carcinogenic agent Substances 0.000 abstract 1
- 231100000433 cytotoxic Toxicity 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 abstract 1
- 229960003964 deoxycholic acid Drugs 0.000 abstract 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1820296P | 1996-05-23 | 1996-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT906106E true PT906106E (pt) | 2008-08-07 |
Family
ID=21786767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97925934T PT906106E (pt) | 1996-05-23 | 1997-05-22 | Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca) |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6426340B1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP0906106B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP2000510858A (cg-RX-API-DMAC7.html) |
| AT (1) | ATE394107T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU3091597A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2253593C (cg-RX-API-DMAC7.html) |
| DE (1) | DE69738667D1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2306459T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT906106E (cg-RX-API-DMAC7.html) |
| WO (1) | WO1997044043A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU758679B2 (en) * | 1998-07-24 | 2003-03-27 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| JP2002522381A (ja) * | 1998-08-06 | 2002-07-23 | ストレンメル，ボルフガング | 粘膜保護用医薬としてのホスファチジルコリン |
| MXPA02003321A (es) * | 1999-09-28 | 2004-09-10 | Panacea Biotec Ltd | Composiciones de liberacion controlada que comprenden nimesulida. |
| US7053076B2 (en) | 2001-08-29 | 2006-05-30 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| EP1558763A4 (en) * | 2002-11-01 | 2007-08-15 | James Kaput | IDENTIFICATION OF GENES ASSOCIATED WITH A DISEASE REGULATED BY A DIET |
| CA2674683A1 (en) * | 2007-01-16 | 2008-07-24 | The Burnham Institute For Medical Research | Compositions and methods for treatment of colorectal cancer |
| EP2255813A1 (en) * | 2009-05-29 | 2010-12-01 | The Royal College of Surgeons in Ireland | Derivatives of ursodeoxycholic acid for the treatment of diarrhoea |
| SMT201800453T1 (it) | 2010-11-04 | 2018-11-09 | Albireo Ab | Inibitori di ibat per il trattamento delle epatopatie |
| JP6751020B2 (ja) | 2014-06-25 | 2020-09-02 | Ｅａファーマ株式会社 | 固形製剤及びその着色防止又は着色低減方法 |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| CA3071285A1 (en) | 2017-08-09 | 2019-02-14 | Albireo Ab | Cholestyramine granules, oral cholestyramine formulations and use thereof |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TW202015699A (zh) | 2018-06-05 | 2020-05-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽汁酸調節劑之用途 |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| FI3810581T3 (fi) | 2018-06-20 | 2025-02-28 | Albireo Ab | Odeviksibaatin kiteiset modifikaatiot |
| GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| ES2937153T3 (es) | 2019-02-06 | 2023-03-24 | Albireo Ab | Compuestos de benzotiadiazepinas y su uso como moduladores de ácidos biliares |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| KR20220109450A (ko) | 2019-12-04 | 2022-08-04 | 알비레오 에이비 | 벤조티아(디)아제핀 화합물 및 담즙산 조절제로서의 이의 용도 |
| CN114761018B (zh) | 2019-12-04 | 2025-12-02 | 阿尔比里奥公司 | 苯并硫杂二氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| ES2973355T3 (es) | 2019-12-04 | 2024-06-19 | Albireo Ab | Compuestos de benzotia(di)azepina y su uso como moduladores del ácido biliar |
| CA3158276A1 (en) | 2019-12-04 | 2021-06-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
| CA3186857A1 (en) | 2020-08-03 | 2022-02-10 | Per-Goran Gillberg | Benzothia(di)azepine compounds and their use as bile acid modulators |
| JP2023549226A (ja) | 2020-11-12 | 2023-11-22 | アルビレオ エービー | 進行性家族性肝内胆汁うっ滞症（ｐｆｉｃ）を処置するためのオデビキシバット |
| CN116583504A (zh) | 2020-12-04 | 2023-08-11 | 阿尔比里奥公司 | 苯并硫杂(二)氮杂环庚三烯化合物及其作为胆汁酸调节剂的用途 |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8825526D0 (en) * | 1988-11-01 | 1988-12-07 | Enzymatix Ltd | Diagnosis |
| US5175320A (en) * | 1989-04-17 | 1992-12-29 | Giuliani S.P.A. | Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| US5843929A (en) | 1996-03-22 | 1998-12-01 | Mayo Foundation For Medical Education And Research | Chemoprevention of metachronous adenomatous colorectal polyps |
-
1997
- 1997-05-22 EP EP97925934A patent/EP0906106B1/en not_active Expired - Lifetime
- 1997-05-22 CA CA002253593A patent/CA2253593C/en not_active Expired - Fee Related
- 1997-05-22 ES ES97925934T patent/ES2306459T3/es not_active Expired - Lifetime
- 1997-05-22 AU AU30915/97A patent/AU3091597A/en not_active Abandoned
- 1997-05-22 WO PCT/EP1997/002632 patent/WO1997044043A1/en not_active Ceased
- 1997-05-22 DE DE69738667T patent/DE69738667D1/de not_active Expired - Lifetime
- 1997-05-22 AT AT97925934T patent/ATE394107T1/de not_active IP Right Cessation
- 1997-05-22 JP JP09541562A patent/JP2000510858A/ja active Pending
- 1997-05-22 PT PT97925934T patent/PT906106E/pt unknown
-
2000
- 2000-10-06 US US09/684,585 patent/US6426340B1/en not_active Expired - Fee Related
-
2009
- 2009-11-02 JP JP2009252071A patent/JP2010059175A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| ES2306459T3 (es) | 2008-11-01 |
| CA2253593A1 (en) | 1997-11-27 |
| WO1997044043A1 (en) | 1997-11-27 |
| US6426340B1 (en) | 2002-07-30 |
| EP0906106B1 (en) | 2008-05-07 |
| JP2000510858A (ja) | 2000-08-22 |
| JP2010059175A (ja) | 2010-03-18 |
| ATE394107T1 (de) | 2008-05-15 |
| AU3091597A (en) | 1997-12-09 |
| CA2253593C (en) | 2008-07-08 |
| DE69738667D1 (de) | 2008-06-19 |
| EP0906106A1 (en) | 1999-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT906106E (pt) | Prevenção e tratamento de cancro colo-rectal pelo ácido 6- fluoroursodesoxicólico (6-fudca) | |
| PL325825A1 (en) | Microemulsion for use as a carrier for administering active compounds | |
| BG102668A (en) | Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x | |
| HRP20020170A2 (en) | Use of inhibitors of the renin-angiotensin system in the prevention of cardiovascular events | |
| IL124459A0 (en) | Antagonists of gonadotropin releasing hormone | |
| MX9804850A (es) | Antagonistas de hormona liberadora de gonadotropina. | |
| AU6147301A (en) | Compositions and methods for the treatment of colorectal cancer | |
| IL134778A0 (en) | Pharmaceutical compositions for oral administration of molecular iodine | |
| MY106528A (en) | Method of treating impotence. | |
| ZA967880B (en) | Compositions and methods for inhibition of the patho-physiologic actions in mammals in tumor necrosis facto-alpha | |
| MY118526A (en) | Method for improving the pharmacokinetics of tipranavir | |
| MY121623A (en) | Methods of preventing breast cancer. | |
| MY118986A (en) | Use of (alpha)-1-adrenoreceptor antagonists in the prevention and treatment of benign prostatic hyperplasia | |
| CA2186867A1 (en) | Methods of Using Iron Chelating Compounds to Reduce Free Radical Damage in Mammals | |
| MY126321A (en) | Use of (alpha)-adrenoreceptor antagonists in the prevention and treatment of cancer. | |
| CA2098593A1 (en) | Treatment method for cancer | |
| WO2001037784A3 (en) | Method for preventing irinotecan induced diarrhea | |
| MX9604692A (es) | Derivados de quinoxalina para el tratamiento de tinnitus. | |
| AU5434899A (en) | Cancer treatment | |
| IL126158A0 (en) | Method for treating substance abuse | |
| WO1995005364A3 (en) | Inhibitors of biogenic amine transporters | |
| WO2001040241A3 (en) | 6-o-alkyl-2-nor-2-substituted ketolide derivatives | |
| DK1019066T3 (da) | Fremgangsmåder og præparater til forebyggelse og behandling af halsbrand | |
| BG106831A (en) | Compound and method for the treatment of pain | |
| NZ503559A (en) | Compositions and methods for the control of smoking containing a xanthine oxidase inhibitor |